Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Megan Xu"'
Autor:
Xiao-Yu Zhang, Yun-Kai Zhang, Yi-Jun Wang, Pranav Gupta, Leli Zeng, Megan Xu, Xiu-Qi Wang, Dong-Hua Yang, Zhe-Sheng Chen
Publikováno v:
Molecules, Vol 21, Iss 9, p 1236 (2016)
In recent years, tyrosine kinase inhibitors (TKIs) have been shown capable of inhibiting the ATP-binding cassette (ABC) transporter-mediated multidrug resistance (MDR). In this study, we determine whether osimertinib, a novel selective, irreversible
Externí odkaz:
https://doaj.org/article/33c88af491ed4394829f69e708532c0f
Autor:
Dieter Braun, Kenneth H. Williford, Thomas Matreux, Jian Gong, Tanja Bosak, Matthew J. Baldes, Mihkel Pajusalu, Victor Sojo, Kelsey R. Moore, Emilie J. Skoog, Tania Feliz Soto, Megan Xu
Publikováno v:
Geobiology. 19:438-449
Microbial fossils preserved by early diagenetic chert provide a window into the Proterozoic biosphere, but seawater chemistry, microbial processes, and the interactions between microbes and the environment that contributed to this preservation are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd2d3a46dc5fda51cf16e6f2798a963
https://doi.org/10.1111/gbi.12447
https://doi.org/10.1111/gbi.12447
Autor:
Leli Zeng, Dong-Hua Yang, Zhe-Sheng Chen, Yi-Jun Wang, Xiao-Yu Zhang, Pranav Gupta, Yun-Kai Zhang, Xiu-Qi Wang, Megan Xu
Publikováno v:
Molecules; Volume 21; Issue 9; Pages: 1236
Molecules
Molecules, Vol 21, Iss 9, p 1236 (2016)
Molecules
Molecules, Vol 21, Iss 9, p 1236 (2016)
In recent years, tyrosine kinase inhibitors (TKIs) have been shown capable of inhibiting the ATP-binding cassette (ABC) transporter-mediated multidrug resistance (MDR). In this study, we determine whether osimertinib, a novel selective, irreversible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de12ea16601e00fd5f1558abc04a86b
Autor:
Pranav Gupta, Zhe-Sheng Chen, Xiu-Qi Wang, Leli Zeng, Yun-Kai Zhang, Yi-Jun Wang, Zi-Ning Lei, Megan Xu, Dong-Hua Yang, Xiao-Yu Zhang
Publikováno v:
Cancer Research. 77:5876-5876
In recent years, tyrosine kinase inhibitors (TKIs) have been shown capable of inhibiting the ATP-binding cassette (ABC) transporter-mediated multidrug resistance (MDR). In this study, we determine whether osimertinib, a novel selective, irreversible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df3a43e201d30b376776526d8e9c81a
https://doi.org/10.1158/1538-7445.am2017-5876
https://doi.org/10.1158/1538-7445.am2017-5876